IP Library › Granted Patent US 12,257,434
Granted Patent B2
US 12,257,434 · App. 18/806,255 · Granted Mar 25, 2025

Carotid sinus nerve stimulation

Inventors: Dimitrios Georgakopoulos (Plymouth, MN); Molly Wade (Carver, MN)
Assignee: BAROLOGICS, INC.
A61N1/36053A61B5/0006A61B5/0205A61B5/282A61N1/36057A61N1/36117A61N1/36135A61N1/36157A61N1/36171A61N1/36175A61N1/36178A61B5/02108A61B5/024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,434
App. No.
18/806,255
Granted
Mar 25, 2025
Kind
B2
Abstract

Methods and systems for stimulating nerve fibers to treat a condition in a patient are disclosed herein. Such methods can include stimulating, via an electrode device, afferent fibers associated with baroreceptors and/or a carotid sinus nerve of a patient; sensing a heart rate of the patient; and adjusting a stimulation frequency of the afferent fibers based on the sensed heart rate. The heart rate can be indicative of an activity level of the patient, and an increase in the sensed heart rate can cause an increase in the stimulation frequency.

Claims (33)

1. A method for stimulating nerve fibers to treat a condition in a patient, the method comprising:

stimulating, via an electrode device, afferent fibers associated with baroreceptors and/or a carotid sinus nerve of the patient;

sensing a heart rate of the patient, wherein the heart rate is indicative of an activity level of the patient; and

adjusting a stimulation frequency of the afferent fibers based on the sensed heart rate, wherein an increase in the sensed heart rate causes an increase in the stimulation frequency.

2. The method of claim 1 , wherein stimulating the afferent fibers comprises sending a stimulation signal from a pulse generator implanted in the patient through a first lead to the electrode device.

3. The method of claim 1 , wherein the electrode device is a multipolar electrode device.

4. The method of claim 1 , wherein stimulating the afferent fibers comprises providing a stimulation signal with parameters in ranges of 1-25 milliampere (mA) amplitude, 0.06-5 millisecond (ms) pulse widths, and 1-5000 Hertz (Hz) frequency.

5. The method of claim 1 , wherein the stimulation frequency is between 80 Hertz (Hz) and 120 Hz.

6. The method of claim 1 , wherein adjusting the stimulation frequency comprises increasing a frequency of the stimulation if the sensed heart rate is above a first predefined threshold and/or decreasing the frequency of the stimulation if the sensed heart rate is below a second predefined threshold.

7. The method of claim 1 , wherein sensing the heart rate comprises using data selected from a group consisting of an electrocardiogram, a blood pressure waveform, a phonocardiograph and an arterial distension waveform.

8. The method of claim 1 , further comprising timing the stimulating by delivering all of a pulse train of the stimulation during a diastolic phase of a heartbeat of the patient.

9. The method of claim 1 , wherein stimulating the afferent fibers comprises selectively stimulating only afferent nerve fibers and not stimulating efferent nerve fibers.

10. The method of claim 1 , wherein the activity level comprises sitting, standing, or walking.

11. The method of claim 1 , wherein the electrode device is flexible and has multiple flaps connected along a first edge and open along a second edge, wherein the second edge is configured to admit the afferent fibers.

12. The method of claim 1 , wherein adjusting the stimulation frequency corresponds to adjusting a number of electrical pulses configured to be delivered to the patient.

13. The method of claim 1 , further comprising adjusting amplitude and/or pulse width based on the sensed heart rate.

14. The method of claim 1 , wherein the sensed heart rate is a first sensed heart rate, the method further comprising:

sensing a second heart rate of the patient; and

adjusting the stimulation frequency based on the second sensed heart rate.

15. An implantable system for stimulating nerve fibers to treat a condition in a patient, the system comprising:

a pulse generator;

an electrode device configured to stimulate afferent fibers associated with baroreceptors and/or a carotid sinus nerve of the patient;

a lead attached and operably coupled to the pulse generator and electrode device; and

a computing device connected to the pulse generator and configured to:

provide a first stimulation via the electrode device;

after providing the stimulation, receive a sensed cardiac cycle from the patient, wherein the sensed cardiac cycle is indicative of an activity level of the patient;

transmit, to the pulse generator, a stimulation frequency correlated to the sensed cardiac cycle, such that an increase in the sensed cardiac cycle causes an increase in the stimulation frequency; and

provide a second stimulation based on the stimulation frequency.

16. The system of claim 15 , wherein the stimulation frequency corresponds to a number of electrical impulses.

17. The system of claim 15 , wherein providing the second stimulation comprises maintaining a number of electrical impulses per cardiac cycle.

18. The system of claim 15 , wherein adjusting the stimulation frequency comprises adjusting the stimulation frequency such that a number of electrical impulses is constant per cardiac cycle.

19. The system of claim 15 , wherein the electrode device is a book-shaped multipolar electrode device.

20. The system of claim 15 , wherein receiving the sensed cardiac cycle comprises receiving a frequency of the sensed cardiac cycle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2025
From: BAROLOGICS, INC.
To: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 071717/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: GEORGAKOPOULOS, DIMITRIOS; WADE, MOLLY
To: BAROLOGICS, INC.
Reel/Frame 068301/0816 →
Continuity (4)
Continuation 17156896 · Jan 25, 2021
Continuation 16393536 · Apr 24, 2019
Provisional Application 62662600 · Apr 25, 2018
Related Publication 20240399150A1 · Dec 5, 2024
References Cited (39)
US 6292703B1 · Meier · 2001 [cited by applicant]
US 7509166B2 · Libbus et al. · 2009 [cited by applicant]
US 8620422B2 · Kieval et al. · 2013 [cited by applicant]
US 9272143B2 · Libbus et al. · 2016 [cited by applicant]
US 9763586B2 · Mokelke et al. · 2017 [cited by applicant]
US 10918865B2 · Georgakopoulos et al. · 2021 [cited by applicant]
US 11819682B2 · Cates et al. · 2023 [cited by applicant]
US 20080140141A1 · Ben-David et al. · 2008 [cited by applicant]
US 20090275997A1 · Faltys et al. · 2009 [cited by applicant]
US 20110046432A1 · Simon · 2011 [cited by applicant]
US 20120033080A1 · Watanabe et al. · 2012 [cited by applicant]
US 20120245656A1 · Brockway et al. · 2012 [cited by applicant]
US 20130131761A1 · Della Santina et al. · 2013 [cited by applicant]
US 20130204328A1 · Stahmann · 2013 [cited by applicant]
US 20140257426A1 · Arcot-Krishnamurthy · 2014 [cited by examiner]
US 20150174396A1 · Fisher et al. · 2015 [cited by applicant]
US 20150202444A1 · Mandred et al. · 2015 [cited by applicant]
US 20160250474A1 · Stack et al. · 2016 [cited by applicant]
US 20170216601A1 · Zhou · 2017 [cited by examiner]
US 20170304630A1 · Plachta et al. · 2017 [cited by applicant]
US 20180056074A1 · Clark et al. · 2018 [cited by applicant]
US 20180104491A1 · Lerner · 2018 [cited by applicant]
US 20180221667A1 · Libbus et al. · 2018 [cited by applicant]
US 20200246623A1 · Libbus et al. · 2020 [cited by applicant]
US 20210145289A1 · Thakur et al. · 2021 [cited by applicant]
US 20210178153A1 · Zaidi et al. · 2021 [cited by applicant]
US 20210205621A1 · Georgakopoulos et al. · 2021 [cited by applicant]
US 20210290957A1 · Schulhauser et al. · 2021 [cited by applicant]
US 20220118250A1 · Libbus et al. · 2022 [cited by applicant]
US 20220134101A1 · Scheiner et al. · 2022 [cited by applicant]
US 20220212006A1 · Rondoni et al. · 2022 [cited by applicant]
US 20230405329A1 · Wade et al. · 2023 [cited by applicant]
DE 19847446B4 · 2010 [cited by applicant]
WO 97018856A1 · 1997 [cited by applicant]
WO 20150108909A1 · 2015 [cited by applicant]
Borst, C. et al., “Optimal frequency of carotid sinus nerve stimulation in treatment of angina pectoris.” Cardiovasc Res. 1974; 8(5); 674-680. [cited by applicant]
Examination Report mailed Mar. 20, 2024 in European Patent Application No. 19729887.0, 4 pages. [cited by applicant]
International Search Report and Written Opinion mailed Sep. 11, 2019 in International Patent Application No. PCT/US19/28935, 14 pages. [cited by applicant]
International Search Report and Written Opinion mailed Sep. 22, 2023 in International Patent Application No. PCT/US3/68319, 15 pages. [cited by applicant]
Cited By (1)
US 12,678,627